Physician profile
Joseph M Armenia
NPI 1770840720
$38,415.41
in general payments reported to CMS, 2019-2025
3 companies · $11K in 2025
The $11K reported for 2025 was more than what 91% of Ophthalmic Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $158 · 2021: $2,288 · 2022: $6,836 · 2023: $8,079 · 2024: $10K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Honoraria: $7,375 · Food and Beverage: $2,831 · Consulting Fee: $850 · Travel and Lodging: $629 · Education: $23.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,425.00 |
| Honoraria | $7,375.00 |
| Food and Beverage | $2,830.54 |
| Consulting Fee | $850.00 |
| Travel and Lodging | $628.88 |
| Education | $23.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21,038.11 | 2024-2025 | Tepezza, Uplizna |
| Horizon Therapeutics Plc | $17,221.68 | 2020-2023 | Tepezza |
| Alcon Vision LLC | $155.62 | 2022-2025 | Clareon Panoptix Pro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Armenia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.